These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6851080)

  • 1. The high performance liquid chromatographic measurement of chloramphenicol and its succinate esters in serum.
    Soldin SJ; Golas C; Rajchgot P; Prober CG; MacLeod SM
    Clin Biochem; 1983 Jun; 16(3):171-7. PubMed ID: 6851080
    [No Abstract]   [Full Text] [Related]  

  • 2. High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinate.
    Burke JT; Wargin WA; Blum MR
    J Pharm Sci; 1980 Aug; 69(8):909-12. PubMed ID: 7400935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of chloramphenicol and chloramphenicol succinate by high-performance liquid chromatography.
    Aravind MK; Miceli JN; Kauffman RE; Strebel LE; Done AK
    J Chromatogr; 1980 Nov; 221(1):176-81. PubMed ID: 7451621
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous determination of chloramphenicol and chloramphenicol succinate in plasma using high-performance liquid chromatography.
    Velagapudi R; Smith RV; Ludden TM; Sagraves R
    J Chromatogr; 1982 Mar; 228():423-8. PubMed ID: 7076772
    [No Abstract]   [Full Text] [Related]  

  • 5. Interference with high performance liquid chromatographic chloramphenicol assay in a patient receiving dobutamine.
    Powel MB; Robinson CA; Furner RL
    Ther Drug Monit; 1985; 7(1):121-2. PubMed ID: 3992619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of chloramphenicol and its succinate ester by high-performance liquid chromatography.
    Nahata MC; Powell DA
    J Chromatogr; 1981 Apr; 223(1):247-51. PubMed ID: 7251773
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1981 Sep; 30(3):368-72. PubMed ID: 7273601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of chloramphenicol and its monosuccinate ester in plasma.
    Oseekey KB; Rowse KL; Kostenbauder HB
    J Chromatogr; 1980 Jun; 182(3-4):459-64. PubMed ID: 7391190
    [No Abstract]   [Full Text] [Related]  

  • 9. A commercial enzyme immunoassay method (EMIT) compared with liquid chromatography and bioassay methods for measurement of chloramphenicol.
    Schwartz JG; Casto DT; Ayo S; Carnahan JJ; Jorgensen JH
    Clin Chem; 1988 Sep; 34(9):1872-5. PubMed ID: 3046781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Need for the determination of chloramphenicol levels in the treatment of bacterial-purulent meningitis with chloramphenicol succinate in infants and small children].
    Forster J; Hufschmidt C; Niederhoff H; Künzer W
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):209-13. PubMed ID: 4000136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients.
    Nahata MC; Powell DA
    Dev Pharmacol Ther; 1983; 6(1):23-32. PubMed ID: 6839912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of chloramphenicol therapy in the newborn infant.
    Rajchgot P; Prober CG; Soldin S; Golas C; Good F; Harding E; MacLeod S
    J Pediatr; 1982 Dec; 101(6):1018-21. PubMed ID: 7143156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of enzymatic and liquid chromatographic chloramphenicol assays.
    Weber AF; Opheim KE; Koup JR; Smith AL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):323-5. PubMed ID: 6957163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloramphenicol serum concentration falls during chloramphenicol succinate dosing.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1983 Mar; 33(3):308-13. PubMed ID: 6825386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic determination of chloramphenicol and four analogues using reductive and oxidative electrochemical and ultraviolet detection.
    Abou-Khalil S; Abou-Khalil WH; Masoud AN; Yunis AA
    J Chromatogr; 1987 Jun; 417(1):111-9. PubMed ID: 3624389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloramphenicol and chloramphenicol succinate concentrations in patients with renal impairment.
    Brasfield JH; Record KE; Griffen WO; Mattingly S
    Clin Pharm; 1983; 2(4):355-8. PubMed ID: 6883963
    [No Abstract]   [Full Text] [Related]  

  • 19. Chloramphenicol sodium succinate kinetics in critically ill patients.
    Slaughter RL; Pieper JA; Cerra B; Brodsky B; Koup JR
    Clin Pharmacol Ther; 1980 Jul; 28(1):69-77. PubMed ID: 7389257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of drug monitoring in patients with bacterial meningitis, eg, chloramphenicol monitoring.
    Rosin H; Crea A; Forster J
    Pediatr Pharmacol (New York); 1983; 3(3-4):175-80. PubMed ID: 6377214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.